Deborah Dunsire, Lundbeck president and CEO
February 18, 2022 01:04 PM EST
Pharma
Marketing

Track­ing men­tal health: Lund­beck part­ner­ship de­buts US map­ping dash­board tool

Beth Snyder Bulik

Senior Editor

While the twindem­ic of Covid-19 and in­fluen­za nev­er re­al­ly ma­te­ri­al­ized, a dif­fer­ent dou­ble cri­sis did. Men­tal health is­sues have boomed along­side Covid cas­es dur­ing the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times